Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Kits Eyecare TSE: KITS reported second-quarter 2026 revenue growth of 17.8% year over year as its prescription-glasses business expanded and repeat customers contributed a larger share of sales. The company also posted net income, record operating cash flow and its 15th consecutive quarter of positive adjusted EBITDA.